Preventive effect of a synbiotic combination of galacto- and fructooligosaccharides mixture with Bifidobacterium breve M-16V in a model of multiple rotavirus infections

dc.contributor.authorRigo Adrover, Maria del Mar
dc.contributor.authorvan Limpt, Kees
dc.contributor.authorKnipping, K.
dc.contributor.authorGarssen, J.
dc.contributor.authorKnol, J.
dc.contributor.authorCostabile, Adele
dc.contributor.authorFranch i Masferrer, Àngels
dc.contributor.authorCastell, Margarida
dc.contributor.authorPérez-Cano, Francisco J.
dc.date.accessioned2019-03-19T11:31:23Z
dc.date.available2019-03-19T11:31:23Z
dc.date.issued2018
dc.date.updated2019-03-19T11:31:23Z
dc.description.abstractRotavirus (RV) causes morbidity and mortality among infants worldwide, and there is evidence that probiotics and prebiotics can have a positive influence against infective processes such as that due to RV. The aim of this study was to evidence a preventive role of one prebiotic mixture (of short-chain galactooligosaccharide/long-chain fructooligosaccharide), the probiotic Bifidobacterium breve M-16V and the combination of the prebiotic and the probiotic, as a synbiotic, in a suckling rat double-RV infection model. Hyperimmune bovine colostrum was used as protection control. The first infection was induced with RV SA11 and the second one with EDIM. Clinical variables and immune response were evaluated after both infections. Dietary interventions ameliorated clinical symptoms after the first infection. The prebiotic and the synbiotic significantly reduced viral shedding after the first infection, but all the interventions showed higher viral load than in the RV group after the second infection. All interventions modulated ex vivo antibody and cytokine production, gut wash cytokine levels and small intestine gene expression after both infections. In conclusion, a daily supplement of the products tested in this preclinical model is highly effective in preventing RV-induced diarrhea but allowing the boost of the early immune response for a future immune response against reinfection, suggesting that these components may be potential agents for modulating RV infection in infants. Keywords: prebiotic, probiotic, synbiotic, rotavirus, FOS, GOS, Bifidobacterium breve
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec686426
dc.identifier.issn1664-3224
dc.identifier.pmid29942312
dc.identifier.urihttps://hdl.handle.net/2445/130527
dc.language.isoeng
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fimmu.2018.01318
dc.relation.ispartofFrontiers in Immunology, 2018, vol. 9, p. 1318
dc.relation.urihttps://doi.org/10.3389/fimmu.2018.01318
dc.rightscc-by (c) Rigo-Adrover, Mar et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Bioquímica i Fisiologia)
dc.subject.classificationPrebiòtics
dc.subject.classificationProbiòtics
dc.subject.classificationMalalties intestinals
dc.subject.otherPrebiotics
dc.subject.otherProbiotics
dc.subject.otherIntestinal diseases
dc.titlePreventive effect of a synbiotic combination of galacto- and fructooligosaccharides mixture with Bifidobacterium breve M-16V in a model of multiple rotavirus infections
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
686426.pdf
Mida:
3.1 MB
Format:
Adobe Portable Document Format